{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:53:52Z","timestamp":1788386032596,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001703","name":"\u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne","doi-asserted-by":"publisher","award":["11C7-HA"],"award-info":[{"award-number":["11C7-HA"]}],"id":[{"id":"10.13039\/501100001703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001703","name":"\u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne","doi-asserted-by":"publisher","award":["FG12-HA"],"award-info":[{"award-number":["FG12-HA"]}],"id":[{"id":"10.13039\/501100001703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["956977"],"award-info":[{"award-number":["956977"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009068","name":"University of Bern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neurot.2025.e00606","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:47:46Z","timestamp":1746726466000},"page":"e00606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modulation of antibody transport in the brain and spinal cord through the intranasal pathway"],"prefix":"10.1016","volume":"22","author":[{"given":"Sebastian","family":"Spiegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Meli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Pernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.neurot.2025.e00606_bib1","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1007\/s11095-015-1728-9","article-title":"Antibody-Drug conjugate (ADC) research in ophthalmology--a review","volume":"32","author":"Shen","year":"2015","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00606_bib2","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/alz.12919","article-title":"CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab","volume":"19","author":"Nisenbaum","year":"2023","journal-title":"Alzheimer\u2019s Dementia\u202f: the journal of the Alzheimer\u2019s Association"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00606_bib3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer\u2019s disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain\u202f: J Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00606_bib4","first-page":"217","article-title":"Disease-modifying therapies and infectious risks in multiple sclerosis","volume":"12","author":"Winkelmann","year":"2016"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00606_bib5","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","article-title":"Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier","volume":"33","author":"St-Amour","year":"2013","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00606_bib6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s13311-020-00864-z","article-title":"Targeting therapeutic antibodies to the CNS: a comparative study of intrathecal, intravenous, and subcutaneous anti-nogo A antibody treatment after stroke in rats","volume":"17","author":"Wahl","year":"2020","journal-title":"Neurotherapeutics\u202f: the journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00606_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00606_bib8","first-page":"579","article-title":"Capture, crawl, cross: the T cell code to breach the blood\u2013brain barriers","volume":"33","author":"Engelhardt","year":"2012"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.05.009","article-title":"Intrathecal delivery of protein therapeutics to the brain: a critical reassessment","volume":"144","author":"Calias","year":"2014","journal-title":"Pharmacol Therapeut"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00606_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1113\/JP275105","article-title":"Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery","volume":"596","author":"Pizzo","year":"2018","journal-title":"J Physiol"},{"issue":"6\u20137","key":"10.1016\/j.neurot.2025.e00606_bib11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/1545968318776371","article-title":"First-in-Man intrathecal application of neurite growth-promoting anti-nogo-A antibodies in acute spinal cord injury","volume":"32","author":"Kucher","year":"2018","journal-title":"Neurorehabilitation Neural Repair"},{"issue":"Suppl 7","key":"10.1016\/j.neurot.2025.e00606_bib12","doi-asserted-by":"crossref","first-page":"S1669","DOI":"10.1093\/clinids\/11.Supplement_7.S1669","article-title":"Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system","volume":"11","author":"Scheld","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00606_bib13","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","article-title":"Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma","volume":"25","author":"Rubenstein","year":"2007","journal-title":"J Clin Oncol\u202f: official journal of the American Society of Clinical Oncology"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00606_bib14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1080\/19420862.2017.1345834","article-title":"Pharmacokinetics of an intracerebroventricularly administered antibody in rats","volume":"9","author":"Noguchi","year":"2017","journal-title":"mAbs"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00606_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","article-title":"Anatomy and physiology of cerebrospinal fluid","volume":"128","author":"Sakka","year":"2011","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00606_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0165-5728(01)00242-9","article-title":"Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier","volume":"114","author":"Zhang","year":"2001","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurot.2025.e00606_bib18","series-title":"Nasal delivery of high molecular weight drugs","author":"Ozsoy","year":"2009"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1567201053586047","article-title":"Intranasal drug delivery for brain targeting","volume":"2","author":"Vyas","year":"2005","journal-title":"Curr Drug Deliv"},{"issue":"2-3","key":"10.1016\/j.neurot.2025.e00606_bib20","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.ddtec.2008.11.005","article-title":"Alternative routes of administration for systemic delivery of protein pharmaceuticals","volume":"5","author":"Moeller","year":"2008","journal-title":"Drug Discov Today Technol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00606_bib21","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41598-019-39191-5","article-title":"Distribution of insulin in trigeminal nerve and brain after intranasal administration","volume":"9","author":"Lochhead","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00606_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12934","article-title":"Intranasal insulin","volume":"33","author":"Hallschmid","year":"2021","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00606_bib23","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200057120","article-title":"Intranasal delivery of full-length anti-Nogo-A antibody: a potential alternative route for therapeutic antibodies to central nervous system targets","volume":"120","author":"Correa","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurot.2025.e00606_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jconrel.2018.08.006","article-title":"Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: distribution, dose-response, and mechanisms of delivery","volume":"286","author":"Kumar","year":"2018","journal-title":"J Contr Release\u202f: official journal of the Controlled Release Society"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00606_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41420-023-01588-7","article-title":"Nogo-A antibody delivery through the olfactory mucosa mitigates experimental autoimmune encephalomyelitis in the mouse CNS","volume":"9","author":"Pernet","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.neurot.2025.e00606_bib26","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00606_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurot.2025.e00606_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1209749","article-title":"Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders","volume":"14","author":"Takai","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2025.e00606_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2023.12.041","article-title":"Nogo-A neutralization in the central nervous system with a blood-brain barrier-penetrating antibody","volume":"366","author":"Joly","year":"2024","journal-title":"J Contr Release\u202f: official journal of the Controlled Release Society"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.103.063222","article-title":"Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration","volume":"309","author":"Banks","year":"2004","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.neurot.2025.e00606_bib31","article-title":"Establishment of an olfactory region-specific intranasal delivery technique in mice to target the central nervous system","volume":"12","author":"Flamm","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00606_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00000542-200109000-00021","article-title":"Low-concentration lidocaine rapidly inhibits axonal transport in cultured mouse dorsal root ganglion neurons","volume":"95","author":"Kanai","year":"2001","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0028-3908(89)90054-3","article-title":"Mechanisms of the inhibition of fast axonal transport by local anesthetics","volume":"28","author":"Lavoie","year":"1989","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00000542-197602000-00009","article-title":"Reversible inhibition of rapid axonal transport in vivo by lidocaine hydrochloride","volume":"44","author":"Fink","year":"1976","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00606_bib35","doi-asserted-by":"crossref","first-page":"17641","DOI":"10.1038\/s41598-018-36210-9","article-title":"Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction","volume":"8","author":"Kamei","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00606_bib36","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s13346-022-01117-6","article-title":"Therapeutic effects of anti-amyloid \u03b2 antibody after intravenous injection and efficient nose-to-brain delivery in Alzheimer\u2019s disease mouse model","volume":"12","author":"Kamei","year":"2022","journal-title":"Drug delivery and translational research"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00606_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111745","article-title":"Investigation of the transport pathways associated with enhanced brain delivery of peptide drugs by intranasal coadministration with penetratin","volume":"13","author":"Kamei","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neurot.2025.e00606_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2014.11.004","article-title":"Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides","volume":"197","author":"Kamei","year":"2015","journal-title":"J Contr Release : official journal of the Controlled Release Society"},{"issue":"Pt 1","key":"10.1016\/j.neurot.2025.e00606_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1107\/S0907444903026350","article-title":"Crystallization of a carbamatase catalytic antibody Fab fragment and its complex with a transition-state analogue","volume":"60","author":"Muranova","year":"2004","journal-title":"Acta Crystallogr Sect D Biol Crystallogr"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00606_bib40","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/lary.21856","article-title":"Immunohistochemical characterization of human olfactory tissue","volume":"121","author":"Holbrook","year":"2011","journal-title":"Laryngoscope"},{"issue":"39","key":"10.1016\/j.neurot.2025.e00606_bib41","doi-asserted-by":"crossref","first-page":"10974","DOI":"10.1073\/pnas.1613026113","article-title":"Development of the main olfactory system and main olfactory epithelium-dependent male mating behavior are altered in Go-deficient mice","volume":"113","author":"Choi","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00606_bib42","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.37.11.1780","article-title":"Intraneuronal IgG in the central nervous system: uptake by retrograde axonal transport","volume":"37","author":"Fabian","year":"1987","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00606_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2008.08.001","article-title":"Usefulness of cell-penetrating peptides to improve intestinal insulin absorption","volume":"132","author":"Kamei","year":"2008","journal-title":"J Contr Release : official journal of the Controlled Release Society"},{"issue":"3 Pt A","key":"10.1016\/j.neurot.2025.e00606_bib44","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejpb.2013.09.014","article-title":"One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats","volume":"85","author":"Khafagy","year":"2013","journal-title":"Eur J Pharm Biopharm : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00606_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jconrel.2010.01.019","article-title":"Structural requirements of penetratin absorption enhancement efficiency for insulin delivery","volume":"143","author":"Khafagy","year":"2010","journal-title":"J Contr Release : official journal of the Controlled Release Society"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00606_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2009.12.060","article-title":"The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides","volume":"388","author":"Khafagy","year":"2010","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00606_bib47","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/mp400681n","article-title":"Penetratin, a potentially powerful absorption enhancer for noninvasive intraocular drug delivery","volume":"11","author":"Liu","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.neurot.2025.e00606_bib48","series-title":"Cell-penetrating peptides","first-page":"355","article-title":"Intranasal delivery","author":"Kamei","year":"2023"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00606_bib49","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1016\/S0021-9258(17)34080-2","article-title":"The third helix of the Antennapedia homeodomain translocates through biological membranes","volume":"269","author":"Derossi","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2025.e00606_bib50","article-title":"Mechanisms of cellular uptake of cell-penetrating peptides","volume":"2011","author":"Madani","year":"2011","journal-title":"Journal of biophysics (Hindawi Publishing Corporation : Online"},{"key":"10.1016\/j.neurot.2025.e00606_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3762\/bjnano.11.10","article-title":"Internalization mechanisms of cell-penetrating peptides","volume":"11","author":"Ruseska","year":"2020","journal-title":"Beilstein J Nanotechnol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00606_bib52","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.20627","article-title":"Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats","volume":"58","author":"Liebscher","year":"2005","journal-title":"Ann Neurol"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00606_bib53","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1523\/JNEUROSCI.23-13-05393.2003","article-title":"Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions","volume":"23","author":"Oertle","year":"2003","journal-title":"J Neurosci\u202f: the official journal of the Society for Neuroscience"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00606_bib54","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1523\/JNEUROSCI.22-16-07097.2002","article-title":"Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord","volume":"22","author":"Bareyre","year":"2002","journal-title":"J Neurosci : the official journal of the Society for Neuroscience"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00606_bib55","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1460-9568.2008.06473.x","article-title":"Neutralization of the membrane protein Nogo-A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures","volume":"28","author":"Craveiro","year":"2008","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00606_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00441-012-1432-6","article-title":"The role of Nogo-A in axonal plasticity, regrowth and repair","volume":"349","author":"Pernet","year":"2012","journal-title":"Cell Tissue Res"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00606_bib57","doi-asserted-by":"crossref","first-page":"10793","DOI":"10.1074\/jbc.M808297200","article-title":"Neuronal Nogo-A modulates growth cone motility via Rho-GTP\/LIMK1\/cofilin in the unlesioned adult nervous system","volume":"284","author":"Montani","year":"2009","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib58","first-page":"271","article-title":"Pincher-generated Nogo-A endosomes mediate growth cone collapse and retrograde signaling","volume":"188","author":"Joset","year":"2010","journal-title":"15408140"},{"key":"10.1016\/j.neurot.2025.e00606_bib59","article-title":"Nogo-A beyond the RhoA\/ROCK pathway \u2013 novel components of intracellular nogo-A signaling cascades","author":"Maibach","year":"2020","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00606_bib60","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1021\/acs.bioconjchem.8b00548","article-title":"Passive immunotherapies for central nervous system disorders: current delivery challenges and new approaches","volume":"29","author":"Kumar","year":"2018","journal-title":"Bioconjug Chem"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00606_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030107","article-title":"Allogenic Fc domain-facilitated uptake of IgG in nasal lamina propria: friend or foe for intranasal CNS delivery?","volume":"10","author":"Ladel","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neurot.2025.e00606_bib62","series-title":"Neuroscience","author":"Purves","year":"2001"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00606_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008445","article-title":"An improved animal model for herpesvirus encephalitis in humans","volume":"16","author":"Sehl","year":"2020","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib64","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12017-009-8099-5","article-title":"Involvement of Fc receptors in disorders of the central nervous system","volume":"12","author":"Okun","year":"2010","journal-title":"NeuroMolecular Med"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2025.e00606_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-5728(94)90176-7","article-title":"Fc receptor for IgG (FcR) on rat microglia","volume":"49","author":"Vedeler","year":"1994","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00606_bib66","first-page":"83","article-title":"Expression of Fc gamma receptors on astroglial cell lines and their role in the central nervous system","volume":"31","author":"Nitta","year":"1992","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/s0304-3940(02)01312-5","article-title":"Expression of Fc receptor for immunoglobulin M in oligodendrocytes and myelin of mouse central nervous system","volume":"337","author":"Nakahara","year":"2003","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00606_bib68","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1534-5807(03)00155-2","article-title":"Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation","volume":"4","author":"Nakahara","year":"2003","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00606_bib69","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1096\/fj.02-1169fje","article-title":"Direct action of immunoglobulin G on primary sensory neurons through Fc gamma receptor I","volume":"18","author":"Andoh","year":"2004","journal-title":"FASEB J : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib70","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0006-8993(71)90044-8","article-title":"Retrograde axonal transport of protein","volume":"29","author":"Kristensson","year":"1971","journal-title":"Brain Res"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00606_bib71","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1212\/WNL.38.11.1775","article-title":"Uptake of plasma IgG by CNS motoneurons: comparison of antineuronal and normal IgG","volume":"38","author":"Fabian","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00606_bib72","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44278","article-title":"Anatomical basis and physiological role of cerebrospinal fluid transport through the murine cribriform plate","volume":"8","author":"Norwood","year":"2019","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00606_bib73","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2044.2006.04901.x","article-title":"Mechanisms influencing the vasoactive effects of lidocaine in human skin","volume":"62","author":"Newton","year":"2007","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00606_bib74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2044.2003.02954.x","article-title":"Mechanisms contributing to the vaso-active effects of prilocaine in human skin","volume":"58","author":"Newton","year":"2003","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00606_bib75","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1471-4159.1996.66031033.x","article-title":"Effects of colchicine application to preganglionic axons on choline acetyltransferase activity and acetylcholine content and release in the superior cervical ganglion","volume":"66","author":"Tandon","year":"1996","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00606_bib76","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","article-title":"Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery","volume":"1788","author":"Deli","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"29","key":"10.1016\/j.neurot.2025.e00606_bib77","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1120800109","article-title":"Transient opening of the perineurial barrier for analgesic drug delivery","volume":"109","author":"Hackel","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00606_bib78","first-page":"391","article-title":"Matrix metalloproteinase-9: many shades of function in cardiovascular disease","volume":"28","author":"Yabluchanskiy","year":"2013","journal-title":"Physiology (Bethesda, Md"},{"key":"10.1016\/j.neurot.2025.e00606_bib79","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1021\/acsmaterialslett.4c00397","article-title":"Cell-penetrating peptides-mediated therapeutic agents delivery into the central nervous system","author":"Wei","year":"2024","journal-title":"ACS Mater Lett"},{"key":"10.1016\/j.neurot.2025.e00606_bib80","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fphar.2020.00697","article-title":"Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application","volume":"11","author":"Xie","year":"2020","journal-title":"Front Pharmacol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:10:29Z","timestamp":1762560629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925000844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1878747925000844"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00606","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of antibody transport in the brain and spinal cord through the intranasal pathway","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00606"}}